Search

everythinglearnresearchcommunity

for

Search:↓

Impaired androgen production in 46,XY DSDs causes ambiguous genitalia and requires long-term care.

AMH helps estimate ovarian reserve but doesn't predict pregnancy chances; age is more important.

Different types of PCOS have different levels of metabolic problems, with the most severe type showing the highest disturbances.

Excessive hair growth in women often has no known cause and is not linked to race or other hormonal symptoms.

High androgen levels in Chinese women with PCOS are linked to a higher risk of diabetes and obesity.

5α-reductase inhibitors and alpha-1 adrenergic antagonists together effectively treat benign prostatic hyperplasia, with long-term benefits.

About 13% of women had idiopathic hirsutism and 8.5% had polycystic ovary syndrome in a group of Iranian women.

Finasteride for hair loss may cause persistent sexual symptoms, depression, anxiety, and lower quality of life.

Spironolactone improved blood vessel function and cholesterol levels in non-obese women with PCOS.

Flutamide reduces hair growth better but has more side effects.

Finasteride effectively treats hirsutism in women, but more research needed for long-term results.

The document concludes with guidance for doctors on diagnosing and treating hirsutism effectively and safely.

Cyproterone acetate plus ethinyl estradiol is generally more effective in treating hirsutism, but consider side effects and patient characteristics.

Women with PCOS often have hair loss, which is linked to acne or excess body hair but not to worse hormone or metabolic issues.

Polycystic Ovary Syndrome is common but often undiagnosed, and early treatment is important to prevent health problems.

Dietary changes, including weight loss and a balanced diet, are important for managing PCOS, especially in overweight women.

The document concludes that understanding and treating hair loss requires recognizing its various types and using appropriate diagnostic tools and treatments.

The document concludes that future heart disease research should account for sex-specific differences to improve diagnosis, treatment, and outcomes.

Spironolactone plus finasteride reduces hirsutism more effectively.

The research suggests that the global distribution of PCOS is likely due to historical human migration and that genes affecting PCOS may have different impacts on males and females.

Hormonal treatments are effective for severe or persistent acne and should be used with other acne therapies, considering potential side effects.

Disrupting Acvr1b in mice causes severe hair loss and thicker skin.

People with polycystic ovary syndrome may have a higher risk of heart problems due to abnormal nervous system control of their heart and blood pressure.

Finasteride effectively treats male pattern hair loss with a 1 mg daily dose.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

To diagnose Polycystic Ovarian Syndrome, two out of three signs—irregular periods, high male hormone levels, or cysts on the ovaries—are needed.

Intense pulsed light (IPL) is an efficient and safe method for hair removal, reducing hair by about 80%.

Gonadal dysgenesis, like Turner's and Klinefelter's syndromes, negatively affects bone health, but hormone treatments can help.

Longer CAG repeat lengths in the androgen receptor gene are linked to higher testosterone levels in women with PCOS.

Lifestyle changes are the main treatment for PCOS, which is a complex condition requiring early management to reduce its health impacts.